A bioengineered murine model using CD24+CD44+ pancreatic cancer stem cells for chemotherapy study

Biomedical Materials (Bristol)

Volumn 10, Issue 1, 2015, Pages

  Qin, Shengqi ^a,b   Deng, Yiming ^b,c   Li, Jianshe ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

cancer stem cell; chemotherapy; electrospinning; gemcitabine; irinotecan; pancreatic tumor

Indexed keywords

CELL DEATH; CHEMOTHERAPY; DISEASES; DRUG PRODUCTS; ELECTROSPINNING; STEM CELLS; TUMORS;

CANCER STEM CELLS; CONVENTIONAL MODELS; ELECTROSPUN SCAFFOLDS; GEMCITABINE; IRINOTECAN; PANCREATIC CANCERS; PANCREATIC TUMORS; SCAFFOLDING MATERIALS;

SCAFFOLDS (BIOLOGY);

GEMCITABINE; IRINOTECAN; MOLECULAR SCAFFOLD; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CD24 ANTIGEN; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; DEOXYCYTIDINE; HERMES ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CD24+ CD44+ PANCREATIC CANCER STEM CELL; CONTROLLED STUDY; CYTOTOXICITY; ELECTROSPINNING; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; ANALOGS AND DERIVATIVES; ANIMAL; BIOMEDICAL ENGINEERING; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; FEMALE; METABOLISM; PANCREATIC NEOPLASMS; PROCEDURES; TISSUE SCAFFOLD;

MURINAE;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOMEDICAL ENGINEERING; CAMPTOTHECIN; CELL PROLIFERATION; DEOXYCYTIDINE; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; TISSUE SCAFFOLDS;

EID: 84924339701     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/10/1/015004     Document Type: Article

References (31)

1. Hidalgo M 2010 Pancreatic cancer N. Engl. J. Med. 362 1605-17
2. Burris H A et al 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 2403-13
3. Borazanci E and Von Hoff D D 2014 Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer Expert Rev. Gastroenterol. Hepatol. 8 739-47
4. Vaccaro V, Sperduti I and Milella M 2011 FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N. Engl. J. Med. 365 768-9 author reply 69
5. Cheon D J and Orsulic S 2011 Mouse models of cancer Annu. Rev. Pathol. 6 95-119
6. Ruggeri B A, Camp F and Miknyoczki S 2014 Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery Biochem. Pharmacol. 87 150-61
7. Capella G, Farre L, Villanueva A, Reyes G, Garcia C, Tarafa G and Lluis F 1999 Orthotopic models of human pancreatic cancer Ann. N Y Acad. Sci. 880 103-9
8. Eastmond D A, Vulimiri S V, French J E and Sonawane B 2013 The use of genetically modified mice in cancer risk assessment: challenges and limitations Crit. Rev. Toxicol. 43 611-31
9. Kubota T 1994 Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation J. Cell Biochem. 56 4-8
10. Li C, Heidt D G, Dalerba P, Burant C F, Zhang L, Adsay V, Wicha M, Clarke M F and Simeone D M 2007 Identification of pancreatic cancer stem cells Cancer Res. 67 1030-7
11. Li C, Lee C J and Simeone D M 2009 Identification of human pancreatic cancer stem cells Methods Mol. Biol. 568 161-73
12. Hermann P C, Huber S L, Herrler T, Aicher A, Ellwart J W, Guba M, Bruns C J and Heeschen C 2007 Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem. Cell 1 313-23
13. Thomas V, Zhang X, Catledge S A and Vohra Y K 2007 Functionally graded electrospun scaffolds with tunable mechanical properties for vascular tissue regeneration Biomed. Mater. 2 224-32
14. Thomas V, Zhang X and Vohra Y K 2009 A biomimetic tubular scaffold with spatially designed nanofibers of protein/PDS bio-blends Biotechnol. Bioeng. 104 1025-33
15. Yin H, Gao M, Leoni L, Han H, Zhang X and Fu Z 2013 The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients PLoS One 8 e57635
16. Yin H, Wang X H, Zhu X D, Han H, Guo W Y and Ful Z R 2013 A tissue engineered renovascular graft composed of proteins, polymers, smooth muscle and endothelial cells for renal artery stenosis J. Biomed. Nanotechnol. 9 1345-53
17. Yong C, Wang Z, Zhang X, Shi X, Ni Z, Fu H, Ding G, Fu Z and Yin H 2014 The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders Int. J. Nanomed. 9 985-93
18. Zhang X, Thomas V and Vohra Y K 2009 In vitro biodegradation of designed tubular scaffolds of electrospun protein/polyglyconate blend fibers J. Biomed. Mater. Res. B Appl Biomater. 89 135-47
19. Zhang X, Thomas V and Vohra Y K 2010 Two ply tubular scaffolds comprised of proteins/poliglecaprone/polycaprolactone fibers J. Mater. Sci. Mater. Med. 21 541-9
20. Zhang X, Thomas V, Xu Y, Bellis S L and Vohra Y K 2010 An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold Biomaterials 31 4376-81
21. Zhang X, Xu Y, Thomas V, Bellis S L and Vohra Y K 2011 Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells J. Biomed. Mater. Res. A 97 145-51
22. Brown B N and Badylak S F 2014 Extracellular matrix as an inductive scaffold for functional tissue reconstruction Translat. Res. 163 268-85
23. Shin H, Jo S and Mikos A G 2003 Biomimetic materials for tissue engineering Biomaterials 24 4353-64
24. Freed L E, Vunjak-Novakovic G, Biron R J, Eagles D B, Lesnoy D C, Barlow S K and Langer R 1994 Biodegradable polymer scaffolds for tissue engineering Biotechnology (N Y) 12 689-93
25. Shrivats A R, McDermott M C and Hollinger J O 2014 Bone tissue engineering: state of the union Drug Discovery Today 19 781-86
26. Fong E L, Martinez M, Yang J, Mikos A G, Navone N M, Harrington D A and Farach-Carson M C 2014 Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening Mol. Pharm. 11 2040-50
27. Xu X, Sabanayagam C R, Harrington D A, Farach-Carson M C and Jia X 2014 A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics Biomaterials 35 3319-30
28. Kim J B 2005 3D tissue culture models in cancer biology Semin. Cancer Biol. 15 365-77
29. Zhang Y, Ouyang H, Lim C T, Ramakrishna S and Huang Z M 2005 Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds J. Biomed. Mater. Res. B Appl. Biomater. 72 156-65
30. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge J S, Polverini P J and Mooney D J 2007 Engineering tumors with 3D scaffolds Nat. Methods 4 855-60
31. Walker E J and Ko A H 2014 Beyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options? World J. Gastroenterol. 20 2224-36